Titelia

Fund shareholders of Royalty Pharma PLC

ISIN GB00BMVP7Y09 · United States · LEI 549300FGFN7VOK8BZR03

Fund shareholders
508
Of which ETFs
147 361 other funds
Value held
5.8B $ 6.3B SEK · 251K €

508 funds hold this company. This table lists the 507 that declare it in a regulatory filing. 1 more fund publishes its holdings in its own report. It is not in the table.

FundSharesValueWeight in fund
Innovator Equity Premium Income - Daily PutWrite ETF Innovator ETFs Trust 452.3K $0.02 %as of Apr 30, 2026 ↗
Avantis Total Equity Markets ETF American Century ETF Trust 321.5K $0.00 %as of Feb 28, 2026 ↗
Global X U.S. 500 ETF GLOBAL X FUNDS 271.2K $0.03 %as of Feb 28, 2026 ↗
SA Franklin Systematic U.S. Large Cap Core Portfolio SUNAMERICA SERIES TRUST 8400.7 $0.00 %as of Apr 30, 2026 ↗
Franklin Allocation VIP Fund Franklin Templeton Variable Insurance Products Trust 3143.9 $as of Mar 31, 2026 ↗
DUNAS SELECCIÓN USA ESG CUBIERTO FI DUNAS CAPITAL ASSET MANAGEMENT S.G.I.I.C., S.A. 168.8K €0.05 %as of Dec 31, 2025 ↗
ARQUIA BANCA LIDERES DEL FUTURO, FI ARQUIGEST, S.A., S.G.I.I.C. 82.2K €0.84 %as of Dec 31, 2025 ↗

Download this table: CSV, JSON

Report an error

The funds most exposed to it

The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.

FundWeight in fund
Discovery Portfolio MORGAN STANLEY INSTITUTIONAL FUND TRUST 8.67 %as of Mar 31, 2026 ↗
Transamerica Capital Growth TRANSAMERICA FUNDS 8.51 %as of Apr 30, 2026 ↗
Global Insight Portfolio MORGAN STANLEY INSTITUTIONAL FUND INC 8.49 %as of Mar 31, 2026 ↗
Discovery Portfolio MORGAN STANLEY VARIABLE INSURANCE FUND INC. 8.37 %as of Mar 31, 2026 ↗
Permanence Portfolio MORGAN STANLEY INSTITUTIONAL FUND INC 8.30 %as of Mar 31, 2026 ↗
Transamerica Morgan Stanley Capital Growth VP TRANSAMERICA SERIES TRUST 8.29 %as of Mar 31, 2026 ↗
Morgan Stanley Discovery Portfolio Brighthouse Funds Trust I 8.14 %as of Mar 31, 2026 ↗
Growth Portfolio MORGAN STANLEY VARIABLE INSURANCE FUND INC. 7.87 %as of Mar 31, 2026 ↗
Global Permanence Portfolio MORGAN STANLEY INSTITUTIONAL FUND INC 7.63 %as of Mar 31, 2026 ↗
GROWTH PORTFOLIO MORGAN STANLEY INSTITUTIONAL FUND INC 7.60 %as of Mar 31, 2026 ↗

Quarter after quarter

Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.

QuarterShareholdersChangeSharesChange
2026Q2444+5120,645,116+5.0 %
2026Q1439-3114,915,379+1.5 %
2025Q4442+18113,214,128-20.3 %
2025Q3424+19142,133,827+16.8 %
2025Q2405+33121,692,643+15.1 %
2025Q1372-10105,719,287+0.4 %
2024Q4382-20105,271,868-7.0 %
2024Q3402+17113,204,330-4.4 %
2024Q2385+11118,423,916+4.4 %
2024Q1374-6113,443,986-4.2 %
2023Q4380118,472,876

Funds holding the debt of Royalty Pharma PLC

341 funds declare 804 bond lines of this company. The table shows the 25 largest holdings. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.

FundBond linesValue
Lord Abbett Short Duration Income Fund3101.6M $as of Feb 28, 2026
VANGUARD TOTAL BOND MARKET INDEX FUND985.5M $as of Mar 31, 2026
VANGUARD INTERMEDIATE-TERM CORPORATE BOND INDEX FUND367.3M $as of Feb 28, 2026
VANGUARD TOTAL BOND MARKET II INDEX FUND866.8M $as of Mar 31, 2026
DFA Investment Grade Portfolio259.3M $as of Apr 30, 2026
VANGUARD SHORT-TERM CORPORATE BOND INDEX FUND342M $as of Feb 28, 2026
Baird Aggregate Bond Fund140.5M $as of Mar 31, 2026
iShares Core U.S. Aggregate Bond ETF1236.1M $as of Feb 28, 2026
VANGUARD SHORT-TERM INVESTMENT-GRADE FUND233.3M $as of Apr 30, 2026
Lord Abbett Income Fund233.1M $as of Feb 28, 2026
LORD ABBETT BOND DEBENTURE FUND INC132.3M $as of Mar 31, 2026
Baird Core Plus Bond Fund129.2M $as of Mar 31, 2026
iShares iBoxx $ Investment Grade Corporate Bond ETF428.1M $as of Feb 28, 2026
VANGUARD WELLINGTON FUND423.5M $as of Feb 28, 2026
PIMCO Long Duration Credit Bond Portfolio619.6M $as of Mar 31, 2026
VANGUARD INTERMEDIATE-TERM BOND INDEX FUND419.2M $as of Mar 31, 2026
iShares 5-10 Year Investment Grade Corporate Bond ETF419.1M $as of Feb 28, 2026
Transamerica Short-Term Bond118.8M $as of Apr 30, 2026
Fidelity U.S. Bond Index Fund317.6M $as of Feb 28, 2026
iShares Broad USD Investment Grade Corporate Bond ETF1216M $as of Feb 28, 2026
Lord Abbett Ultra Short Bond Fund114.8M $as of Feb 28, 2026
iShares 1-5 Year Investment Grade Corporate Bond ETF314.5M $as of Feb 28, 2026
LVIP Franklin Templeton Core Bond Fund314M $as of Mar 31, 2026
VANGUARD SHORT-TERM BOND INDEX FUND312.7M $as of Mar 31, 2026
Schwab 5-10 Year Corporate Bond ETF412.1M $as of Mar 31, 2026
Cite this page

Titelia. "Fund shareholders of Royalty Pharma PLC". https://titelia.com/en/stocks/royalty-pharma-plc-GB00BMVP7Y09